Study addresses role of gene in treating diabetes, liver disease

God forbid if your a heavy drinker and you are imbibing your liquor with high fructose laden soft drinks.

Inhibiting the gene PGC-1b may play an important role in treating non-alcoholic fatty liver disease, type 2 diabetes and insulin resistance caused by an increased consumption of high fructose corn syrup, according to Yale medical researchers in the March issue of Cell Metabolism Journal.

Normally, PGC-1b regulates liver glucose and lipid metabolism while simple sugars are converted into fatty acids in the body, Cell Metabolism reported. However, when the body is introduced to large amounts of high fructose corn syrup, PGC-1b increases the actions of an element binding protein that causes fructose-induced insulin resistance, leading to non-alcoholic fatty liver disease and type 2 diabetes.

Read the Entire Article at The Daily Toreador